DoW Alzheimer?s Transforming Diagnosis Award

The fiscal year 2026 Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis. The key features of this award include: • Clinical research is allowed, but clinical trials and animal research are prohibited. • Preliminary data are required. • Community collaboration is required for studies prospectively enrolling human subjects. • The study population may leverage existing cohorts/datasets, and cohorts consisting of individuals 65 years or younger are also encouraged. • A Career Initiation or Transition (CIT) Partnership Option is available, which supports both new and existing collaborative partnerships.